Search Details

Word: ebert (lookup in dictionary) (lookup stats)
Dates: during 1970-1979
Sort By: most recent first (reverse)


Usage:

...early 1969, Medical School Dean Robert Ebert was appointed to the Board of Directors of Squibb Beach-Nut, Inc. -As a director, Ebert held 267 shares of Squibb stock--valued at--about $15,000. He also received a yearly salary of several thousand dollars...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

During the summer of 1969, Ebert decided that his Squibb post might give the appearance of conflict of interest with his administrative duties. He decided to resign from the Board, but was persuaded by Squibb President Richard Furlaud, a personal friend, to remain with the company as a "public director" owning no stock and receiving no salary...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

...when a group of medical school students protested in October 1969 that any association with the pharmaceutical company's board compromised "the first obligation of a physician or teacher of physicians...to the patient," Ebert resigned his post. "There are those," he said in explaining his decision, "who, in all sincerity, feel that my continued membership on the board could be subject to misinterpretation...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

Three years later, Dean Ebert appeared before an FDA Advisory panel which was holding a hearing on Squibb's Mysteclin-F, a drug which had been severely criticized by a National Academy of Sciences-National Research Council panel of thirty specialists on infections diseases. Critics argued that prescription of Mysteclin-F's fixed combination of several antibiotics was irrational since it tended to give the patient too much or too little of each of the antibiotics, rather than the precise dosage needed...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

Squibb needed big names to defend the embattled Mysteclin-F, and it called on two of the biggest names in academic medicine, both on the Squibb payroll: Dean Ebert (a Squibb consultant), and Dean Lewis Thomas of the Yale Medical School a member of the Squibb Board of Directors...

Author: NO WRITER ATTRIBUTED | Title: Ebert and Squibb | 12/6/1972 | See Source »

Previous | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | Next